42 /100
MEDIUM RISK
Score updated Apr 13, 2026

HRTX

Heron Therapeutics, Inc. — Stock Dilution Tracker

Track HRTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track HRTX — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
37
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
29%
🔁 Convertible Conversion 40%
• Significant convertible debt: 20% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split 30%
• 50-day avg $1.03 approaching $1 threshold
🔔 Track HRTX — Get forecast alerts →
💹 Market Data
Market Cap$160.82M
Shares Outstanding188.54M
Float133.74M
Cash$46.63M
Debt$140.64M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 7.8% shares (2025Q4 vs prior)
169 institutional holders · 157.81M shares
#1 Rubric Capital Management LP 30.05M shares
#2 Clearline Capital LP 12.24M shares
#3 ADAGE CAPITAL PARTNERS GP, L.L.C. 11.19M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest39.42M
Days to Cover18.4
% of Float29.5%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2023
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track HRTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HRTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required